NME1 has also shown to enhance total NHEJ activity in A549 (lung adenocarcinoma) [28], U2-OS (osteosarcoma) and HEK293 (embryonic kidney) cells but was reported to exert no impact on HR activity [27]. The gene discussed is NME1; the disease is osteosarcoma.